Newsroom | 41630 results

Sorted by: Latest

Medical Devices
-

Shape Memory Medical Secures $10 Million Financing Led by August Global Partners to Advance Aortic Clinical Programs

SAN JOSE, Calif.--(BUSINESS WIRE)--Shape Memory Medical Inc., developer of proprietary shape memory polymer technology for endovascular embolization, today announced the closing of a $10 million convertible note financing led by new investor August Global Partners (AGP), joined by fellow new investor Taiwania Capital. The financing provides capital to support continued clinical development of the company’s aortic portfolio, including patient follow-up and data collection in the AAA-SHAPE Pivota...
-

OSI Systems Reports Fiscal 2026 Fourth Quarter and Fiscal Year Financial Results

HAWTHORNE, Calif.--(BUSINESS WIRE)--OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced its financial results for the three months and fiscal year ended June 30, 2026. Ajay Mehra, OSI Systems’ President and Chief Executive Officer, stated, “Fiscal 2026 was a strong year for the Company, capped by record fourth quarter non-GAAP earnings per share and record operating cash flow, despite the impact of revenue headwinds from the Middle East conflicts which shifted the...
-

FDA Clears C2N Diagnostics’ PrecivityAD2® — First Alzheimer’s Blood Test for Adults with Cognitive Symptoms as Young as 40

ST. LOUIS--(BUSINESS WIRE)--The U.S. Food & Drug Administration (FDA) has cleared C2N Diagnostics’ PrecivityAD2® test, providing patients and health care professionals with an accurate, accessible, and scalable blood test to help diagnose Alzheimer’s disease in conjunction with standard clinical workup. An estimated 19-20 million U.S. adults aged 65 and older, and hundreds of thousands more between ages 45 and 65 are living with cognitive impairment and may benefit from an early diagnosis1....
-

UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the 17th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL

NEWBURYPORT, Mass.--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), today announced Mitchell Rock, President and Chief Executive Officer, and Ron Lataille, Sr. Vice President, Treasurer and Chief Financial Officer, will present and host 1-on-1 meetings at the Midwest IDEAS Investor Conference on Wednesday, August 26, 2026 at The InterContinental in Chicago, IL. The company’s presentation is scheduled to begin at 8:35 AM CT. The presentation is webcast and can be accessed through the con...
-

Verasonics Appoints New Senior Vice President, Research & Development

KIRKLAND, Wash.--(BUSINESS WIRE)--Verasonics names Richard Van Bibber, Ph.D. as SVP of R&D. He will lead ultrasound research innovation and advance product development strategy....
-

ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation and Sustainability

DUBLIN--(BUSINESS WIRE)--ICON releases 2025 ICON Cares Report, highlighting progress in patient impact, innovation and sustainability...
-

Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings

GUILFORD, Conn.--(BUSINESS WIRE)--FDA-cleared Optive AI software enhances Swoop system image quality, clinical utility, ease of use, and isotropic imaging capability....
-

Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and Medigen Vaccine Biologics Corp. (MVC) collaborate on the characterization and validation of the virus seed bank for MVC's next-generation multivalent enterovirus vaccine. Charles River will leverage its advanced analytical platforms, including Next-Generation Sequencing (NGS), to support critical steps of Chemistry, Manufacturing, and Controls (CMC) activities for MVC’s next-generation multivalent...
-

Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2026 Results

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2026 results on Thursday, August 27, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, August 27, 2026, at 8:30am ET. To view, listen to, and participate in the live webcast, please follow the link below: https://events.q4inc.com/attendee/768174807 To l...
-

Aztron Medtech Receives Presidential Award, Accelerates U.S. Commercial Expansion

NEWARK, Calif.--(BUSINESS WIRE)--Aztron Medtech receives Taiwan's Presidential Award and NT$10 million grand prize, accelerating U.S. expansion and orthopedic innovation....